Type something to search...
Adult Products Often Get Rejected for Patents in China—Why?

Adult Products Often Get Rejected for Patents in China—Why?

China’s Patent Scene: Huge Opportunities, but Article 5 is a Hidden Minefield

China’s paAdult productsploding—global $50B by 2027 (Statista), with China leading manufacturing (Dongguan & Shenzhen). Yet Article 5 of the Patent Law is a silent killer, blocking grants for inventions seen as violating “social morality” or public interest. Designs saw a 15% rejection spike in 2024 due to visual cues, but utility and invention patents can stay steady if drafted right. The issue? Examiners tag products as “non-medical artificial sexual substitutes,” sparking morality checks. From my examiner chats and database dives, if descriptions scream “intimate,” initial reviews flop.

Article content Kegel Exercises: Your “Medical Shield” to Bypass Article 5

How to flip it? Kegel exercises are your secret weapon. Developed by Dr. Arnold Kegel in the 1940s, these pelvic floor workouts help millions with incontinence, postpartum recovery, and quality of life (PubMed studies). In patents, a line like “vibration modes simulate Kegel contractions for muscle strengthening” shifts from “toy” to “health aid.” Why? The 2023 guidelines say non-medical substitutes violate morals; Kegels provide real medical evidence (GB/T 14895-2010 standard), and examiners nod at that. In a case I handled, this turned a “no” into approval—but don’t fake it; unsubstantiated claims risk fines.

Article content patent illustration Drafting Magic: Lessons from a Smooth Success Case

Drafting is the real art. Take CN223666103U, an “insertable electric massager” granted December 2025 without issues—just 10 months. It nailed it by focusing on “vibration mode indicators” over intimacy. CNIPA data shows medical-framed patents hit 85% approval in 2024, vs. 40% for pure adult ones. Here’s their techniques vs. pitfalls I’ve fixed

Article content This echoes trends: 2023 guidelines stress public acceptance—Taobao sales or Shanghai expos aren’t “immoral.” But controversies persist: Unproven health claims lead to rejections. Examiners aren’t anti-innovation; they just need proof it’s beneficial, not boundary-pushing.

For Global Players: Stack US/EU Patents

For global players, stack US/EU patents—USPTO’s lenient on health claims, perfect for Amazon enforcement.

Faced challenges in sensitive tech patents? Share below—I’d love your stories!

#PatentStrategy #AdultWellness #ChinaIP #KegelInnovation #EntrepreneurJourney

Key Citations:

China National Intellectual Property Administration (CNIPA) Database Statista Adult Wellness Market Report PubMed on Kegel Exercises Beijing IP Court Case (2019) Jing 73 Xing Chu 3870 2023 Patent Examination Guidelines

For more article, visit our Linkdedin newsletter: https://www.linkedin.com/newsletters/china-ip-gateway-7392039659566153728/

Related Posts

Practical Answers
How Much Can You Really Amend Claims When Entering China via PCT?
By Peter Lin/ On 15 Dec, 2025

How Much Can You Really Amend Claims When Entering China via PCT?

Amending claims when you enter China's national phase via PCT sounds straightforward — but CNIPA applies strict "no new matter" rules that trip up many applicants. Peter Lin explains what's actually permitted, what gets rejected, and how to amend smartly.

Insights
How to Protect Your Idea Quickly in China: A Personal Note from the Train
By Peter Lin/ On 01 Dec, 2025

How to Protect Your Idea Quickly in China: A Personal Note from the Train

As I sit on a high‑speed train to Xiamen to meet with clients, I’m writing this post because I’ve been getting the same question lately from international founders: “How can I protect my idea in China before it’s even ready for market?” In the U.S., many startups rely on a provisional patent application. It’s like a placeholder that locks in your filing date for 12 months while you refine your product. It’s affordable, flexible and gives you breathing room to perfect your design. But China plays by different rules. There is no provisional system. So what can you do? The answer lies in a unique strategy: filing a utility‑model patent and an invention patent at the same time.